A loss in a management report invites an understandable question: why are we continuing this activity? Finance should welcome that question. It should also ask what the reported loss means for the choice being proposed. If a cost allocated to the activity would remain after closure, the company cannot count its disappearance merely by moving the allocation to another column. The arithmetic of the report may be correct while the claimed saving answers a different question.
The report was accurate but the proposed inference was not
In our FY 2024 review, a research line generated ₹7.2 crore revenue. Its account carried ₹4.9 crore avoidable costs and ₹3.5 crore allocated central costs, producing a ₹1.2 crore reported loss. The closure proposal described that loss as an improvement the company could obtain by ending the line. I initially found the argument persuasive. A negative result appeared to offer a clear priority, and the organisation had other demands on its attention.
Anita, our research leader, asked which resources would actually disappear. That question changed the discussion. Over the decision period, the ₹3.5 crore central cost would remain. The line was contributing ₹2.3 crore toward those continuing costs before allocation. Closing it could remove that contribution without removing the shared expense. The report had not necessarily been prepared incorrectly; we were using it to support a claim about a decision that required a different comparison.
I needed to own that distinction because finance had supplied the account. It would have been easy to say that research colleagues had misunderstood an allocation. In fact, I had allowed the reported result to carry more decision authority than it deserved. A useful CFO should not defend a familiar reporting format when the enterprise is asking a question the format was not designed to answer. The response should improve the decision account while preserving whatever purpose the original allocation serves.
We therefore separated costs that closure could change from common costs that would continue. We also examined the period over which the comparison applied. A cost that remains for six months may become adjustable over a longer horizon, and a resource that cannot be eliminated may be capable of serving a different purpose. Those possibilities should be stated and assessed rather than treated as either immediate savings or permanent impossibilities. The relevant question is what the proposed action can change, when and through whose decision.
Continuing is a choice with its own opportunity cost
The ₹2.3 crore contribution did not settle the line's future in its favour. It established that the original closure argument was incomplete. Research capacity is finite, and a positive contribution can still be inferior to another credible use of the same people and attention. Customer relevance may weaken, or the service may need a change in scope. I did not want the revised calculation to become a new slogan that protected every activity producing something above its avoidable cost.
This is where finance and research needed to work together. Research leadership could assess the value of the line and the alternatives for its team. Finance could make the economic consequences comparable and identify assumptions that required evidence. Neither function should quietly make the other's judgement. I am not the author of the company's economic conclusions. Anita is not responsible for making a common cost disappear simply because the allocation produces an uncomfortable result. The enterprise decision requires both perspectives.
We proposed six months of continuation with a defined commercial and research review. Rohan accepted that recommendation. Continuing meant retaining an option to understand the line better, but it also meant using capacity that might otherwise have gone elsewhere. The review period was therefore not a costless postponement. It needed a purpose and an account of what would be learned, otherwise the phrase further review could become a polite way to avoid making any difficult portfolio choice.
Over the subsequent six months, the line produced ₹3.4 crore revenue against ₹2.5 crore avoidable costs. The ₹90 lakh difference was contribution before common costs. It was not net profit, and the six-month result could not be compared directly with the earlier annual account as proof of improvement. I kept those limits in the presentation because a review intended to correct one misleading inference should not end by creating another. The result informed the next choice; it did not give the line permanent protection.
A review period should answer a question
The value of a temporary continuation depends on what management does with it. If the same report returns six months later with a different date and the same unresolved assumptions, the company has paid for delay rather than learning. I wanted the discussion to examine demand, the resource choices and the credible alternatives. The financial result was one part of that assessment, not a substitute for deciding what the research business should offer or how it should organise its capacity.
A board can help by asking management to distinguish a reporting result from an action consequence. What expense is avoidable? Which resource can be redeployed? What remains because of existing commitments? What alternative use is sufficiently developed to compare? Those questions need not turn directors into cost-accounting analysts. They require management to explain the proposed decision in terms of the enterprise, not only the line whose report happens to show a loss.
There is also a communication responsibility toward the people affected. A closure discussion based on a claimed saving can become difficult to reverse without appearing indecisive. That is another reason to examine the comparison before a headline hardens into an announced conclusion. Finance should be clear about what is known and what remains a proposal. Colleagues should not have to infer that their work has no value because a central allocation has produced a negative number, nor assume that positive contribution means the business can never change direction.
I would now place the decision comparison alongside the reporting account from the start. Both can be useful. The allocated account may help explain how the enterprise distributes common expenditure; the decision view explains what changes under an action. Reconciliation between them prevents the discussion from becoming a contest over which version is the truth. They answer different questions, and the CFO should make that difference explicit before asking executives to choose.
The lesson I took from Anita's challenge was a modest but consequential one: an accurate number does not become relevant to every decision simply because finance prepared it. In this case, a ₹1.2 crore reported loss did not describe ₹1.2 crore of improvement available on closure. Once we understood that, the company could consider the line on a more honest basis, including the possibility of changing or ending it later. Precision did not remove the difficult choice. It gave the choice back to the people responsible for making it.